A Thousand Advisory Committees, and More from CRS
As of last year, there were 1,009 federal advisory committees comprised of 72,220 members who provided advice to the government at a cost of more than $367 million.
The operations of these federal advisory committees — which may also include commissions, councils, task forces, or working groups — are examined in a newly updated report from the Congressional Research Service. See Federal Advisory Committees: An Introduction and Overview by Wendy Ginsberg and Casey Burgat, October 27, 2016.
Other new and updated CRS reports that have not been made publicly available online include the following.
Bahrain: Reform, Security, and U.S. Policy, updated October 28, 2016
Iran: Politics, Human Rights, and U.S. Policy, updated October 25, 2016
Israel: Background and U.S. Relations, updated October 28, 2016
Ukraine: Current Issues and U.S. Policy, updated October 27, 2016
Navy Aegis Ballistic Missile Defense (BMD) Program: Background and Issues for Congress, updated October 25, 2016
Navy Virginia (SSN-774) Class Attack Submarine Procurement: Background and Issues for Congress, updated October 25, 2016
Navy Columbia Class (Ohio Replacement) Ballistic Missile Submarine (SSBN[X]) Program: Background and Issues for Congress, updated October 25, 2016
Department of Homeland Security Preparedness Grants: A Summary and Issues, October 28, 2016
DHS Appropriations FY2017: Security, Enforcement, and Investigations, October 27, 2016
Treatment of Noncitizens Under the Affordable Care Act, updated October 27, 2016
Video Broadcasting of Congressional Proceedings, October 28, 2016
The Social Security Retirement Age, October 28, 2016
Social Security: Calculation and History of Taxing Benefits, updated October 27, 2016
Did a Thermostat Break the Internet?, CRS Insight, October 26, 2016
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.